Logo

respiratory infection

Lumos Diagnostics Expanding Rapid Respiratory Test Portfolio Following Australian IPO
Premium

The firm completed a clinical study to apply for US regulatory clearance for FebriDx, its single-use, instrument-free assay for respiratory infections.

DARPA Programs Leveraging Host-Response Testing, CRISPR for Future Pandemic Preparedness
Premium

DARPA program managers said they are developing different testing modalities that are crucially linked in their objective to facilitate more comprehensive and faster testing.

With Diagenode Acquisition, Hologic Expects to Expand Panther Fusion Testing Menu
Premium

Diagenode already sells more than 30 real-time PCR tests that are CE-marked for the detection of bacteria, parasites, and viruses for multiple infectious diseases.

Lumos Diagnostics Signs Canadian Distribution Deal for Acute Respiratory Infection Assay

The test is designed to help determine if a patient has an acute respiratory infection and if that infection is bacterial or viral.

GenMark Diagnostics Q4 Revenues Rise 84 Percent on MDx Sales

GenMark said its ePlex molecular diagnostic product revenue for Q4 was $45.4 million, an increase of 138 percent over the fourth quarter of 2019.

Jan 8, 2021

Breath-Based Diagnostics Gain Traction as Potential Method for Detecting SARS-CoV-2
Premium

Jan 6, 2021

360Dx Index Jumps 31 Percent in 2020 as COVID-19 Shifts Attention to Dx Industry

Dec 30, 2020

Roche Diagnostics, Beckman Coulter, BioMérieux, Mesa Biotech Receive FDA 510(k) Clearances in November

Dec 2, 2020

BARDA Awards $12.7M to Chembio to Support FDA Submissions for Respiratory, SARS-CoV-2 Antigen Tests

Nov 20, 2020

Illumina, IDbyDNA Flesh Out Sequencing-Based Respiratory Tests

Nov 16, 2020

Qiagen Obtains CE Mark for Multiplex Respiratory Infection Test, Saliva-Based SARS-CoV-2 Assay

Nov 11, 2020

OpGen Posts 70 Percent Increase in Q3 Revenues Amid Shuffling of Portfolio

Nov 9, 2020

SpeeDx Partners With Nepean Hospital on Respiratory Viral Illness Test

Nov 5, 2020

Luminex Q3 Revenues Rise 35 Percent on Coronavirus Testing Demand

Oct 14, 2020

Tempus Enters Infectious Disease Market With Large-Scale COVID-19 Testing, Data Initiative

Oct 13, 2020

Enzo Biochem Q4 Revenues Down 7 Percent

Oct 8, 2020

GenMark Sees Jump in Preliminary Q3 Revenues, Nabs Respiratory Panel FDA Emergency Use Authorization

Oct 6, 2020

BioFire Diagnostics, UMass Medical Coronavirus Tests Get FDA Emergency Use Authorization

Sep 24, 2020

BARDA Awards $5.4M to Luminex for Expanded Respiratory Panel With Coronavirus Target

Aug 3, 2020

NHS Will Roll Out COVID-19 Tests From DnaNudge, Oxford Nanopore Across UK

Jul 15, 2020

BioMérieux BioFire Respiratory Panel With SARS-CoV-2 Target Nabs CE Mark

Jul 9, 2020

Qiagen Reports Preliminary Q2 Revenue Growth of 18 to 19 Percent

Jul 3, 2020

CDC Combined COVID-19/Influenza Test Gets FDA Emergency Use Authorization

May 4, 2020

GenMark Diagnostics Q1 Revenues Grow 80 Percent

Apr 30, 2020

AMP, CAP, Others Request Medicare Coverage for Respiratory Panel Tests